Page last updated: 2024-10-25

debrisoquin and Esophagitis

debrisoquin has been researched along with Esophagitis in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shah, RR1

Other Studies

1 other study available for debrisoquin and Esophagitis

ArticleYear
Symptomatic bradycardia in association with H2-receptor antagonists.
    Lancet (London, England), 1982, Nov-13, Volume: 2, Issue:8307

    Topics: Aged; Bradycardia; Debrisoquin; Esophagitis; Female; Furans; Histamine H2 Antagonists; Humans; Ranit

1982